Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.36 |
| ▸ | LAP3 | P28838 | 2/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2311014 | 0.91 | PLA2G2C (0.44) | PLA2G2CPTPN1 | |
| SCHEMBL1963907 | 0.91 | PLA2G2C (0.44) | PLA2G2CPTPN1 | |
| SCHEMBL4444982 | 0.91 | PLA2G2C (0.44) | PLA2G2CPTPN1 | |
| SCHEMBL4435691 | 0.91 | PLA2G2C (0.44) | PLA2G2CPTPN1 | |
| SCHEMBL1965773 | 0.91 | PLA2G2C (0.44) | PLA2G2CPTPN1 | |
| SCHEMBL1964499 | 0.90 | PLA2G2C (0.41) | PLA2G2CPTPN1PLA2G2DLPAR3LPAR1 | |
| SCHEMBL1964225 | 0.90 | PLA2G2C (0.41) | PLA2G2CPTPN1PLA2G2DLPAR3LPAR1 | |
| SCHEMBL1964153 | 0.89 | PLA2G2C (0.43) | PLA2G2C | |
| SCHEMBL1962712 | 0.89 | PLA2G2C (0.43) | PLA2G2C | |
| SCHEMBL1964685 | 0.89 | PLA2G2C (0.43) | PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0845981-B1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORP (US) | 2002-09-25 | — | — | EP | claimed |
| EP-0845981-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1998-06-10 | — | — | EP | claimed |
| WO-1997046223-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1997-12-11 | — | — | WO | claimed |
| EP-4301341-A1 | LOADING OF ALGINATE MICROSPHERES | Board of Regents, The University of Texas System (US) | 2024-01-10 | — | — | EP | disclosed |
| EP-3972566-A1 | RADIOTHERAPEUTIC MICROSPHERES | Board of Regents, The University of Texas System (US) | 2022-03-30 | — | — | EP | disclosed |
| WO-2020237042-A1 | RADIOTHERAPEUTIC MICROSPHERES | PHILLIPS WILLIAM T (US) | 2020-11-26 | — | — | WO | disclosed |
| WO-2020118271-A1 | FIBRIN-TARGETED POLYMERIZED SHELL LIPID MICROBUBBLES | NANOVALENT PHARMACEUTICALS, INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| EP-2909230-A1 | STABILIZATION OF BIOMIMETIC MEMBRANES | Danisco US Inc. (US) | 2015-08-26 | — | — | EP | disclosed |
| WO-2014063097-A1 | STABILIZATION OF BIOMIMETIC MEMBRANES | DANISCO US INC. (US) | 2014-04-24 | — | — | WO | disclosed |
| EP-2709590-A1 | ENHANCED GROWTH INHIBITION OF OSTEOSARCOMA BY CYTOTOXIC POLYMERIZED LIPOSOMAL NANOPARTICLES TARGETING THE ALCAM CELL SURFACE RECEPTOR | Nanovalent Pharmaceuticals, Inc. (US) | 2014-03-26 | — | — | EP | disclosed |
| EP-2637649-A2 | COMPOUNDS AND METHODS FOR TREATING PAIN | Akron Molecules GmbH (AT) | 2013-09-18 | — | — | EP | disclosed |
| EP-2430151-A2 | MENIGOCOCCUS VACCINE CONTAINING LIPOOLIGOSACCHARIDE (LOS) FROM MODIFIED STRAINS OF L6 IMMUNOTYPE NEISSERIA MENINGITIDIS | Sanofi Pasteur (FR) | 2012-03-21 | — | — | EP | disclosed |
| EP-2429531-A2 | USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES ASSOCIATED WITH VASCULATURE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2012-03-21 | — | — | EP | disclosed |
| WO-2011149985-A1 | POLYMERIZED SHELL LIPID MICROBUBBLES AND USES THEREOF | NANOVALENT PHARMACEUTICALS, INC. (US) | 2011-12-01 | — | — | WO | disclosed |
| WO-2010131116-A2 | USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES ASSOCIATED WITH VASCULATURE | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010130898-A2 | MENIGOCOCCUS VACCINE CONTAINING LIPOOLIGOSACCHARIDE (LOS) FROM MODIFIED STRAINS OF L6 IMMUNOTYPE NEISSERIA MENINGITIDIS | SANOFI PASTEUR (FR) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010059963-A2 | PREPARATION AND METHODOLOGY OF SILK FIBROIN NANOPARTICLES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2003101482-A2 | LIPOSOME VACCINE FORMULATIONS FOR FIN-FISH | GENESIS GROUP INC. (CA) | 2003-12-11 | — | — | WO | disclosed |
| EP-0845981-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1998-06-10 | — | — | EP | disclosed |
| WO-1997046223-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND CO-LIPIDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOLECULES | GENZYME CORPORATION (US) | 1997-12-11 | — | — | WO | disclosed |